clastoban800 ml
Riassunto delle Caratteristiche del Prodotto

01.0 DENOMINAZIONE DEL MEDICINALE -[Vedi Indice].

02.0 COMPOSIZIONE QUALITATIVA E QUANTITATIVA - [Vedi Indice].

03.0 FORMA FARMACEUTICA - [Vedi Indice].

04.0 INFORMAZIONI CLINICHE - [Vedi Indice].

04.1 Indicazioni terapeutiche - [Vedi Indice].

04.2 Posologia e modo di somministrazione - [Vedi Indice].

04.3 Controindicazioni - [Vedi Indice].

04.4 Speciali avvertenze e precauzioni per l'uso - [Vedi Indice].

04.5 Interazioni - [Vedi Indice].

04.6 Gravidanza e allattamento - [Vedi Indice].

04.7 Effetti sulla capacità di guidare veicoli e sull'uso di macchine - [Vedi Indice].

04.8 Effetti indesiderati - [Vedi Indice].

04.9 Sovradosaggio - [Vedi Indice].

05.0 PROPRIETA' FARMACOLOGICHE - [Vedi Indice].

05.1 Proprietà farmacodinamiche - [Vedi Indice].

05.2 Proprietà farmacocinetiche - [Vedi Indice].

-1.3 %쏢 5 0 obj <> stream x]nEW.@gv$dr @ER dR zsOMPT W׻=Y׫<+U>~:W8x}efkO^~{tٷ�Z=?ȳ+ӌߋU٘.WmeoMT__7tUխʋW*80EjS4Y::~;&Rvyޯ|hk/Oc쯲:] fb_Ra0>K$0:e5Kf[-jSPP^maL]VmcnmB-ʼmaRa>eS,$T(KOBmu첶ȶ8(fux_ 3|{|p뿭q&}oZgn8MQ7M6am?&;K̮GᦴqeV>yu4tTU'iTyYD_SjnD[l#=$So ltƸ솚&løIrK*2̟m)sˀX7u[ڕϿ ߌΝ[g'V~uXgzzȳm|Ǻ'ޞb^Zhڦ^_KᛁH K-|ٶ]чu~/]ÙԸ''[FuhBͦk`gMq)WcEfx ?7Ñ;"/62< O ?&}Eb^`Lټ tQuM@0 +ͧ᧹7MT[YEKzzik{Vm-~/; $Z*)h O6Sv9j:+eG= BW=~yceSܪ[w͏uv@mͧb (pg# t <.(WgE.;pQKo#^fkt-L64^pgxR5f`ShZԘ,GQ׍P#Jhp]?ݮRصFbgkW$ I\tLԏȆ.I)VX9EU .wmັ3{+xf DI|VRz- asai!#G㳓, }|譛3Q< \FPaõY/%)&*R u[V XUSb.9UN*Y=`+W[DA4aA5qq] j갬Q&c vY0zTιy2- ) TO\Y AULJ9#8,M]dw(`.H_C#.݄ Wi"㌼ip˨X_ @3AihMu~3Mm t.rTG^Ǫ@^qo"/([/|[oF*rfƗqm]W~h<܀3.>[>R]{W1G ^蘻5L//AF VD?D,?ZOE}$Rk\4Mh]0>Yn^8+qYLLde݅oxRHKiu1e7(ΖUt&Q+e>B{ȑqޣҨrq7u&FKG1G1' R&"b@sC8F`Ǥ*K2&mLJ?\BkSr¨\,ƞJLhゟȾ CSYٞ;&ĸ78 & UKXUU <9(Vu){[uUX:XU7gw&]L }Sޮ٠'@+qi439$&I2"8`I 4Y|< F|Ġ;]b?;`Zsj!jOI )7+!E*97z]Kh#w;XX94y e?J'2T3g|м t H-ltN <6,3Azlf!m;]uըF]߉(FUmC DCõG91/a%`ܲZ䅥Zcw&N~tb#U7VejKb,1I<)wȚ&Eɀ>M̍fMF*moEa}Z?!kaL9鄡g?+evo^AHGJy$\ckW0NK\s˽]ޖL"b[aCZ9!#L@hłv[~224:O$)rVDs;I K"fm/ĭ&DZ咊%bag׽OXy[:Qiub_d jId^ }C|NQG %qƈՕf ]k y ĕHرfϱkPRW#>c3UsxlƟ+6 |WVР-Cj:`RFC 7F0-8mm]Q.3!2CjKGcso&#dBep۴ם&LwcgD528]т4݄]t`rxj6kz9ՎT9 r# ,=Cqm%p8I\AM"M ]OLw__.q5͝M 'l̄=-V}XG&y4"xu\ϗ"d2VY|RD kdt+*WVdKï9b<<TR\uX൓Ӂpe-vLI[4P]vs1GXxj̺\" vdNʼnr')qPEp*+ E /<:/SPκUe GSuַ5H nY-ɥY,~tv֋QG[!][*P4o0Lx[Lc䪭׋s;c:^y!7ggvNILIbW ő׊*k(pIOJ.?'B%3WqZ\y2bB l'^탽',"$p'Ax^)-oi?Ѕ+o ۛҺpYn*dt]\22& Y~o(;4э DH=pw}A1V/r$fV NSi9Tq'~-+v+ #%"%*an?|o (0UvJ*Ah|CwJG;nbn٬`UJ貼Ȼ{}ZNS"kg8t=f=DГXc?Spq<Ɵ.UyMw甼$^ȘޱߔjS aTS/ {Juۂ_=J` ^b V&2gq2ɞdñ+ƥttY/WxWfxI|P62Е,;_gO endstream endobj 6 0 obj 5263 endobj 15 0 obj <> stream x]r$Gr+63&Q9N K/ch4Du HPdfDUH5?lvEYmvӿwg͟> E="3"_eܔek6v8nb]YTwg PVm.?ŮƱm1]6ceW.]m*?O3noMb,Dz4MMoNݮj\ieQW4 ]W2W۽(w#:>Kk3ѱ~(G3yz{'w;ЭizlA/S?>z50U`f ="4"Mnn07 TQi0^Y ES.o~r35~WU#vM<_z7=lڡa!wfһqF,3vMc&8-�|M^,PYmNe_)ahF|odnW ~`90ю^j9~cc]o:0`Os](< W/dhƲYP,cB՚"kF_~fa4rNC?3{XnL-dOncDDg//TͮMrVG^4 4D=ܪ̯WQFD6u\e_Zv[2^#dJ O ǰ{<@$ Fݜ`B( q/<R\TэRԠƨ[/)M/Hp=VGgHlsBdp}Ɛ[_m0\/i1t翯C.iRY>Jt;mJB`eBK7 `wo -nfcos um3 D"'--b=D7WEb:Q4<pl@*|)bWS_5 kTpε"cLԻ@ga{$K*[ %8*_ %mVB[I*K}/S3-ӊbm3|/&5ctx^3NM(R 7D]i)׋>P~ &ƄDƸ(7x#O?y}rDA$6'oz˴sʷ26]x^a8 7>}uP fF,ۭFWb, %ٶW$aCl1=7KǦֆD*lm7zA{ huX}'XhLAcL,>y):P"%HdqJ0S'f^+{S!\zitֽ%^ *u\uÀЍ`PteD_v9=*~<7k%\Imm?D[a]7ދ4b!%B -155@q/T˨i ؀P|pt%bчtD_* xۇ,ItA_A7W1EF=<@2NRGͶ+q{/G/)WN)TOPNJP`v{Ny駃O}iIW ]Z'n86_qlKl,H\Al>Gx6ʅ MhnMp/W[U>I ~>`~]I%y'TJ7 `gl9AUf/\"KIncrKUomjIנL?qR.-RBE@ -pbXkʹʉ#RqrKi j;XTPDt .nj-]%?xm7v"FY6 9y)h19E6*Bu{'J[BWodYN-.V,F̙1vR{ntzhvlXM yw{N@9ܤjY`AT^: *݄!N1}Ek,ʫ4^({6G-,H(0" ]ŵpX RtɤK1KY$;e 9eg:ڣ ՞apH(рa;ppLC!K,oS:)bEh P$ :ָr*zԥ( %X *I$"=k+Y(Ƚ!?mjTp_ [LGH.ut-aTDr+nU^RDm.$N0] ^%'$װZgdzvm MrhMy={E)qXO?MWTg^C}{I @j)A`jՅGuyK0Pcdyҿ@Tw EI8y;T&вre^h*atE_8Xg_sI3*KƂsLhSQ[cZ!+V؟OILj跉UO;-׆#s&l#x 6LrVIxxz7[_oP[Bm qޜcbgS91!cGb(C|[ T-uΑ0P<2mB#n"Ώ aC5r$0'#ם10Y\D\^x^Fhz.b,�7^dAg) RKL"ZmǪ"EfEHY1Jfa8miS/>Ci%ut&&y`]H$EkXTSo4O@EϰfDJM8c-nD$rM:@mmL=t/uIJրqNL.P"EKrb(Z"*7$/3ҬU\Ώ_3fpyD!#2L`ޢ<6]:0LkN 0rb 8defoAXGRlWUl@Ϣ45]e=8ԁvHh:[ ȬG=S'io|tYC{l|,0?8up51aMC fHE=:bUxIdJ|\cwW%O<#=lK:/`h \}`s2o,R#ZUhH&S gNʰ /sIR (,o=%BܨpH| M9ukTT'[kE - kQ\A"jok^^s{"oE Qݲ\-ȆMx0ZĴִ3Яv](\Xd{,[z~ɴ{׀R\v(zs6bY7ʞT,Pm" uG( #I4+Sli:cэ bY3K݅K #}s#%ʃ9ҎP!:jSW^<8oBI'zswE Җ)Swf=w#RLAMr_?1EtihBhD|@up[&Q3F.Y38PU|JN-KQh 9რ>zevBgg]2!+}Έؓ4&_~:}JSANK>[ٖZCElh\@cTX ϔBeIy]O4AxNlm7 MG+y͓25g~q2w㻜&bS6,iSw i)*OJu,Ll=])R+迌ABF$2tU fzB ; `Ơeqyo:r5]D@5Sz2=%وgLkL/߲$흀8X(sړ_Ed%JQѩ4>=0S@IwеLNq戀(Z]mwC):2"IQWA&G3,01a*b-hTƈP+>`H%GA3_kbu!U[2(Bh:*-lA2ًxZ6P#5ڰdo�yLnB̿K2\INQ#~@e0tö//f|r|& Idup~S(em9\)Ow c^+)HKGxOc`#bƝo(vg^h ,^5]JƗc!SlS[6ZBSI`z/?Gv9}U^b2aJ֘Ua)e0%nZv{(U@_}GDpJ%zr )§GA%Z44/jY\~*b}(0qQhvm]dTlwbq .Ox!;}PI2Ͻ*Z݌aLgxک` )UF,YNG< LPT1<[|q@eԨ#xLEIkߞ Q0:0,|e\D Wv$km&7%S}t"`:썪/˾bzwe}\E 7_AjV^_vnZz-텿H}1y[# 3Dט_]Z+w̖}V=鄵do0_BI 'i8D8Ty2-< >@Z 8z?ŵ$ A9gvTZ ^Qc铟3K-ָjЃ`X-"Yʒ)&QRʪ1ek.P=UwmSu4RR lyq jz͇Slv{{ؔ)i* u: .c**7OYo[RQ:fxH(UP hT.^ѻ[ ]^'E-*| ; paɍTj z\ W~%j8D~PױB+ b1w%stM3ٓ{W^;VL[h"oG'([e&Xm2F·jVA2;+>ȗC`wsS4>4gBpD/e,$E9ub? .Sh&W~0Z3' Vu4>+tM35N k JԘYKg{*ǩ)jUbxK'dF&ѻhsBtnb݂0a~ę7RaԎY|̓."/wS14}QM>6Rw%rGfzXr2X޹bgXendstream endobj 16 0 obj 6452 endobj 19 0 obj <> stream x]rƵ+8IsR&%*vJIl_fMR"]EɢJg 54'@^ PKU({~>BU_:z7==ӷRE>;*q4Nhw?AWPeQ}UUSGcSZTMQ Ck)T?6vR8C5ݹ~,F5*; ?OE;,{ajwiM߫h޽ޟA ֭~_P 7(~kҶԫJ~P#|G~(ƶFjzSs^SuHY(p7uVe f8Vq3-Y[zu-Eiɺߏ*o0[:$&EYP6Ht+}-ga7BIz`[Z9Po/dأ:?A?]zV~еۢk{r Df$P9dmǯ/=/Ng ^󠴰) EwLLoVeh</"}b {fa}'pl*k-G2lT`gqM:qe%K9dX2Ps|Wl\(ٱ|9ArAՀ#˶P d4@/.㹵wmko[ Pl *To*a%,xBph:3Y"YH]P2ey{ 9WKa5p4huF8c3ʑڽgcPJ 6U="6"nw3xqU{.(ö /M{U~OY}=П}sԎqێJS}qsGhU : 0[ḯMѩ:r Y~T8PHM F Ĉ?ECHLB,@jX ''epǼ~!1M$~gPTcэ^HidJ:&|8Sx ۠w D=ܔ(U / 2b;y,+][R}匃xGH*91 po1FNhHH)~vU*,-rPNMޥqA0 C2z(vs%n,ZGvI]!zO-Ƕz:ˎ5P/ReL`qN@/j^kb "bF@ /973ĚLf *KVKI}]/Ș=[a[ 3ʩnd4+Dӷ}f245eѾV(I?`%A*17]{3!FPd&*1DO=˧RF؅aL.W ΁7ބxLvнXet<~C}}K= Cӏ F٣gִH]? usd.ʍv%̌y]]Q @R^s PeRnT'WloR[mK(Dywm_7!~_ݙر_XDiQ)DNR#*+Coa",uSAtn"u0U憻.HAY qH(t,-!]lDa5m] BM:#Ty4f ][4e;`Y\A3O^!"a]JhB+@)Kf\*eTxY1э#]kZۦRqH1kV;G4J3_$]V 9$}*6T=L[ޮlV(MwIA g*1̙(<)Fa?@4FaZ`K$6>GC * O=/PzD~gin[.y~p>@-P.OT5pj<9뱗Gg]I\oKd̲RD "s1^lFfTa۸NFyUܖ QK`P߫I;]"\3E7Nklyb !q&P؆wЫra䆸zI3PM/ir[[▵ ޤ#v!H٨|L23h8`8NR]}5 n'k[ex}<aƉC"$T;Uxs 7Pn@JL rPc]?h0$S }Z|R E۰K EAy#PVHlww?c s&+GCFPie1Ye >GwqZͦ t<f;Xw+ߘĽP[qa.l +1`[>GGB) i]qT--:3-Gb3<0suIN-ZK!Լ+Ŝb^ #a]hln,Uuzլ H|ɘB]yȹhYfNxrg̣z5Eu%,f2e#WqֹilȼXgEɱ&O:'G@Tw>5l>G)`ര2H":(|FDs| -1iLfLj23G @B [4IcmG GHr+5T1;!sN(9E~ϬJ{}r\$R'(Lc$$(F$nBp05#;##2ZNqh!ɞm(yƨـ'jOU(1zwCn Ӕf`p,$bҽYX&i.5$E[^j"DaK@vN/w 0鞀27 7s̡uZHd}џn弘n,(a+#$M%0gm`o&8M+Xpd8߬2XLQ^7VK3oPkLrbI;cUoe;4T8d5B:ΗlC/֝Cr*٣,`7ͰaAUMTc e nٛt 4Jx]%[Xd"PVtA5-j}aihiAif˧y4^Șz]OaF|5ǶQÖAN#:s_)1#H(T|$Zx=cSpO͘ YP4IPLq)PX| ="5"~|JļA"+KpOF6> 1.g:]JEUVkdq~~Z:_lj WвW议# wW}?=AG0) ^d\$''z\d w\B-XXC=$v*Axck9qAG+?wsSsSDx#ڜĔ,TmX`c2*R};҄4ujΑ<`љgSq>TSFV$[AR " -M!^j]}DGW0q萿teu8]wEG5RK" 3F@-kpr4j-[36#5,abk}ٌo?FW1]D[i 6or36m]tgU8 ҼUcT)ZAπ஥Ib4ms}6H 7L>wctott ]WRl.%!vej%ȑI8RDM;/qd#° 6r>8le`{ƃfƟOȉw觉6]YOHl>fI /rOqvJ<$XdB5]Ye""˷/JKRwZm%N/G-:%Lʥ4bF& .` ECͺF1MZykDQ>RvnΩI'^O'Z<.(D6>\֖o\is;ReEEM,!='"1H\0eSVo:835:H}H-L5<ծgӄTgk[g=uOay_J! X0/:v{U "upq6R;$IWP+sPߐxŽFtAPtA;<3K ^ :QM1:q5xƨ- oqn[qXl /aD94endstream endobj 20 0 obj 6142 endobj 23 0 obj <> stream x[rS%;f0n4$vM.UI("*9<yOBvekmݔBzqWݽ->Md t&r*pkJ%,4݂NJktն&.O/YKs2ܙS/lv&P"\O8Z7j1DFa$;fsҝ .hn؏00l FЗ7\$ ̑\LìAO@T6B}ؼ&ktϜ7{~(,ʈM6 )a,@8D_W79N7ԇFϓ;y7 1(!m&C ]g  I󄒯E96B4:ԳNAL-Cn=ہgiR9Ӝ>7"YLVՂ-3[\SftCu#;H0tbȃ&޲ ׁTla$7y.xeg)8{f1q8} hFoSx-c@|B&%%xK/6)ƱLa-wgߩ7U3QiډhlLa Y4BCX9o-*_xOO_jS4/$i.v=i5.ä ȑ-lG(.`p1(\�Y׎*r# gYF,`X ]p(}6j6Mr=1v 86!24 |avBPr 3"+1<(Ʌ`6-KMN,ǗZbNbR aJq0؀ų՚V4OM|iNbtȳ*_HhAKNbtU1:Mdl# f-V`s z<3Z0?I`Wl`AoS'YDz5t&Udn2+eH8ԧtứ4PvfT'*fxuɎU~fK9%>A،܈?is /̯QN}nʘ7WuBy^'x ;*Z4" UMBԨ_#wutn{V8'zQjPK-+2K{˩4e8^`gY7QI|QrK)UZ h00Y6G|/|+Ui�s,#[ŝ=PhS&?Pkv9PsG2=Ĥ4U 3tWI6pTE#!r."oNrԊx+ .n v#hivw4ꄊ:5o__ep@}!* s}uOA )ITLfGHGKφ>(mhP7R&OlSg?m>m L""ϯ$~(?&F%4{LK/aT]CН&ٚhra)T(W{`աT6Ȓ( :*L+~%Q!F"K#=RۏQ޽cB]ο|,C<3ۅ5#~GlLc{eEAz[&3US ~O\ت`y䯽uϏN0GBidG&+i="5"yi:US3{bsrݗ=%T֎y?Ɩٽ[ @O+,Us,YDfQ} C' 1&7GHV!;&Ӫ'~ӄncSRlӥ{P R3%JMx>b; NJfʐ+6}ؠ!Vb<+IS>0L3>3gz(ͼ'3c;@+$p1ɘw^ݲ(t'iZ=C`k$JmtWL> l@0MCu$D]A #ԭޒNG'g9ؾYYf#ke:lF9"䝬)RQe&erv.gLo 3M|s2k0:6E@K;4B"FlnVEJq⿟,j * _Zh="3"7KdӛVսO ٻ,?e1.80 endstream endobj 24 0 obj 3038 endobj 4 0 obj <> /Contents 5 0 R >> endobj 14 0 obj <> /Contents 15 0 R >> endobj 18 0 obj <> /Contents 19 0 R >> endobj 22 0 obj <> /Contents 23 0 R >> endobj 3 0 obj << /Type /Pages /Kids [ 4 0 R 14 0 R 18 0 R 22 0 R ] /Count 4 /Rotate 0>> endobj 1 0 obj <> endobj 13 0 obj <> endobj 17 0 obj <> endobj 21 0 obj <> endobj 25 0 obj <> endobj 10 0 obj <> endobj 8 0 obj <> endobj 12 0 obj <> endobj 27 0 obj <> endobj 7 0 obj <> endobj 28 0 obj <> endobj 9 0 obj <> endobj 29 0 obj <> endobj 11 0 obj <> endobj 26 0 obj <>stream xX}xչϙl>&$& ,%5 IV $R& f1'[/7乂'iVf7\Dmb{>ګԫZ 1OKg6PrK9;;y{ Aڢ0ܧ1es0hȲm}߭B捡͡% hkoLgl_{kpKU v̰?Hfy훻{fy-D;k6 %᪐?}ͭS]ɡήDaCCxU( r ;7dYIdNx2a9 Ư!rq\b y݋| ' cg g!<~wzx0Ёkslnxِp8@!8 OcgA4Gq#d!qfZA6@.4~dt.Ѝ1ȇ(6Oq8b En(x.hp6XË{7d菌su dN8M.fti07F߅_;y_t>! #7Jp;! g>"5S~qhFOPnٶAI%%Ed= #? p"gz!}_h8A6+f΃12EPK jkш߃uZ<řoFIU?=qbi(q]H$d㼗zr?FdG`,MONbz!`dEIUFMrRn{>_?%>(r9Q.(\BwF0./Y\zۢ%7TX7~-oAup/ooyuk4Ukw$0SD+5{!9LMworhv8a),燀+> R:K;/U˛G b8+_ -xcBıфx?L25rtV&.)GNowb5&&$r4lJ?",:i{z!mmf;09q2&Jx8fC= ߡ b웤YB /3ƆWm-^nÍ*,< ~<ۅ $mr$R'Bm$ Xk{qFm;zRl?+Ms0Dsv`-&o/O<k3,ȿMxV!Aqnq`8O+) l)WK6)Kʔ )UJ$)I%*'LKīY?U$y:]P+o]]/M^ߖo| @Gn;z>`Wk[՜OEy2o-hSqyk}sz s^VY! ]#d~<qb @&aV O(A@(IV&x ym@W7=z;ܮh[I&ggj%|+þhCɚ>)3=+>jZGqĬ+nGH ԛՓ2gB:BB8q7# X8qxbZ[×Nz¿Z+O Cf@u"z߶v۬(ѾSϼ@sK;+iե.%8tS7( |!kjnyxX\sua:X͇>lllf7VJP\(iJ2鯰YC̭tӾ19)xK4S3j{RwtcS*+3p/O}zjjgytdkwSww#tnTw_* mJ0WukSDa`NXm|BF"^R`iuu%%bw/{Iӛ1M0 ,}хOQ[QhSKH83k'. Ifʕ24I endstream endobj 2 0 obj <>endobj xref 0 30 0000000000 65535 f 0000021942 00000 n 0000027009 00000 n 0000021853 00000 n 0000021279 00000 n 0000000015 00000 n 000

05.3 Dati preclinici di sicurezza - [Vedi Indice].

8 00000 n 0000022577 00000 n 0000022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

06.0 INFORMAZIONI FARMACEUTICHE - [Vedi Indice].

06.1 Eccipienti - [Vedi Indice].

000 n 0000022577 00000 n 0000022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

06.2 Incompatibilità - [Vedi Indice].

n 0000022577 00000 n 0000022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

06.3 Periodo di validità - [Vedi Indice].

00022577 00000 n 0000022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

06.4 Speciali precauzioni per la conservazione - [Vedi Indice].

2577 00000 n 0000022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

06.5 Natura e contenuto della confezione - [Vedi Indice].

00000 n 0000022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

06.6 Istruzioni per l'uso e la manipolazione - [Vedi Indice].

00 n 0000022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

07.0 TITOLARE DELL'AUTORIZZAZIONE ALL'IMMISSIONE IN COMMERCIO - [Vedi Indice].

0000022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

08.0 NUMERI DELLE AUTORIZZAZIONI ALL'IMMISSIONE IN COMMERCIO - [Vedi Indice].

0022264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

09.0 DATA DELLA PRIMA AUTORIZZAZIONE/RINNOVO DELL'AUTORIZZAZIONE - [Vedi Indice].

264 00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 000002

10.0 DATA DI REVISIONE DEL TESTO - [Vedi Indice].

00000 n 0000022751 00000 n 0000022199 00000 n 0000023024 00000 n 0000022326 00000 n 0000021990 00000 n 0000021421 00000 n 0000005368 00000 n 0000011892 00000 n 0000022060 00000 n 0000021565 00000 n 0000011913 00000 n 0000018127 00000 n 0000022110 00000 n 0000021709 00000 n 0000018148 00000 n 0000021258 00000 n 0000022160 00000 n 0000023224 00000 n 0000022484 00000 n 0000022658 00000 n 0000022833 00000 n trailer << /Size 30 /Root 1 0 R /Info 2 0 R /ID [<3EF6BEF49F0A64545D0EBF72AA63CF6F><3EF6BEF49F0A64545D0EBF72AA63CF6F>] >> startxref 27231 %%EOF

 

 

Ultimo aggiornamento: 15/12/2008.

Prontuariofarmaci. - Copyright © 2000-2009 - Anibaldi.it@Network - Tutti i diritti riservati.